Sumitomo Mitsui Trust Group
NRIX icon

Sumitomo Mitsui Trust Group’s Nurix Therapeutics NRIX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$15.9M Buy
1,391,638
+635,668
+84% +$7.24M 0.01% 644
2025
Q1 		$8.98M Sell
755,970
-33,252
-4% -$395K 0.01% 698
2024
Q4 		$14.9M Buy
789,222
+235,971
+43% +$4.45M 0.01% 679
2024
Q3 		$12.4M Buy
+553,251
New +$12.4M 0.01% 690